Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-01-27
Original SEC Filing: Click here

---

Webplus: SVA/20140127/6-K/2_EX-99.1/000.htm SEC Original: v366318_ex99-1.htm
Sinovac Holds 2013 Annual General Meeting of Shareholders BEIJING, Aug. 21, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it held its 2013 Annual General Meeting of Shareholders on Wednesday, August 21, 2013 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted

---

---

Webplus: SVA/20140127/6-K/3_EX-99.2/000.htm SEC Original: v366318_ex99-2.htm
Sinovac to Participate in UBS Asia Healthcare CEO Summit in November 2013 BEIJING, Oct. 31, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Weidong Yin, Chairman, President and CEO of Sinovac, is invited to participate in UBS Asia Healthcare CEO Summit held in Hong Kong on November 1,

---

---

Webplus: SVA/20140127/6-K/4_EX-99.3/000.htm SEC Original: v366318_ex99-3.htm
Sinovac to Host Conference Call to Report Third Quarter 2013 Unaudited Financial Results EIJING, Nov. 4, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the third quarter ended September 30, 2013, after market closes on Tuesday, November 12, 2013 EST. The Company

---

---

Webplus: SVA/20140127/6-K/5_EX-99.4/000.htm SEC Original: v366318_ex99-4.htm
Sinovac Receives Jiangsu Province Tender Award to Supply Inactivated Hepatitis Vaccine Healive(R) under Expanded Immunization Program BEIJING, Nov. 7, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has been selected by the Jiangsu Centers for Disease Control and Prevention (Jiangsu CDC) to supply the Company’s inactivated hepatitis A vaccine, Healive, under the

---

---

Webplus: SVA/20140127/6-K/6_EX-99.5/000.htm SEC Original: v366318_ex99-5.htm
Sinovac Reports Unaudited Third Quarter 2013 Financial Results – Conference call scheduled for Wednesday, November 13, 2013 at 8:00 AM EST – BEIJING, Nov. 12, 2013 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for for the three and nine months ended September 30, 2013. 2013

---

---

Webplus: SVA/20140127/6-K/1/000.htm SEC Original: v366318_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-01-27CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085